Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France and Its Use in Routine Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PILOTE
- Sponsors Amgen
- 14 Feb 2017 Planned End Date changed from 1 Sep 2018 to 1 Jul 2018.
- 08 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Feb 2016 Planned End Date changed from 1 May 2018 to 1 Sep 2018 as reported by ClinicalTrials.gov.